Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrignendum to the Detailed Public Statement under Regulation 18(7) in terms ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 3.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aftertrade Broking Pvt Ltd, acting as the Manager to the Offer, has submitted a Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement to BSE. This filing is made under SEBI's Regulation 18(7), which governs substantial acquisitions of shares and takeovers. The submission indicates that an open offer has been triggered, likely as part of a change of control or acquisition transaction involving the company's shares. The specific details of the offer, including the offer price and number of shares sought, would be detailed in the full advertisement document.
This filing signals that an open offer has been initiated for Aspira Pathlab & Diagnostics Ltd, which may lead to a change in control or substantial shareholding acquisition. Shareholders should monitor for the detailed offer terms, including offer price and timeline, as this could impact the stock's near-term performance.